Patrick Long, MD
Clinical Genetics (M.D.) · Denver, CONPI 1740676683
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Amgen accounts for 75.8% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $2,122 and has fallen 76.5% since, to $498 in 2025.
Across 40 payments — averaging $111.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- Sanofi$584
- AstraZeneca$166
- Alnylam Pharmaceuticals Inc.$152
- Takeda Pharmaceuticals U.S.A., Inc.$51
- Springworks Therapeutics, Inc.$33
- plus $90 from 4 others
What the payments were for
- Speaking & faculty fees$2,32052%
- Travel & lodging$2816%
- Food & beverage$1,84441%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 16 | $3,368 |
| Sanofi | 7 | $584 |
| AstraZeneca(2 entities) | 2 | $166 |
| Alnylam Pharmaceuticals Inc. | 7 | $152 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Springworks Therapeutics, Inc. | 1 | $33 |
| Pharming Healthcare, Inc. | 1 | $27 |
| Biomarin Pharmaceutical Inc. | 1 | $23 |
| Mirum Pharmaceuticals, Inc. | 1 | $23 |
| Biogen | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical genetics (m.d.) providers in Coloradoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical genetics (m.d.) in Denver
- Janet ThomasAurora$66K
- Matthew TaylorAurora$41K
- Shawn McCandlessAurora$33K
- Jessica DuisAurora$25K
- Austin LarsonAurora$22K
- Aaina KochharAurora$11K
- Peter BakerAurora$7K
- Margarita SaenzAurora$2K
- Johan van HoveAurora$117
- Farrah RajabiAurora$26
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.